Amanote Research
Register
Sign In
BET Protein Inhibitor JQ1 Downregulates Chromatin Accessibility and Suppresses Metastasis of Gastric Cancer via Inactivating RUNX2/NID1 Signaling
Oncogenesis
- United States
doi 10.1038/s41389-020-0218-z
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Molecular Biology
Date
March 1, 2020
Authors
Siqi Zhou
Shu Zhang
Lei Wang
Shuling Huang
Yue Yuan
Jie Yang
Hui Wang
Xihan Li
Pin Wang
Lin Zhou
Jun Yang
Yuemei Xu
Huan Gao
Yixuan Zhang
Ying Lv
Xiaoping Zou
Publisher
Springer Science and Business Media LLC
Related search
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
BET Inhibitor Suppresses Neutrophil-Dependent Lung Metastasis of Inflammatory Renal Cancer Cells
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Plasminogen Activator Inhibitor 1 RNAi Suppresses Gastric Cancer Metastasis in Vivo
Cancer Science
Cancer Research
Medicine
Oncology
Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation
Cancer Research
Cancer Research
Oncology
A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways
Cancer Research
Cancer Research
Oncology
CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma
Cancer Research
Cancer Research
Oncology
JQ1, an Inhibitor of the Epigenetic Reader BRD4, Suppresses the Bidirectional MYC-AP4 Axis via Multiple Mechanisms
Oncology Reports
Medicine
Cancer Research
Oncology
Arsenic Sulfide Amplifies JQ1 Toxicity via Mitochondrial Pathway in Gastric and Colon Cancer Cells
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
The Proteasome Deubiquitinase Inhibitor bAP15 Downregulates TGF-β/Smad Signaling and Induces Apoptosis via UCHL5 Inhibition in Ovarian Cancer
Oncotarget
Oncology
